Biotechnology, Genetics, Biochemistry

Telomere biology, drug discovery, cancer genetics

•Tyrone C. Otgaar, Eloise Ferreira, Sibusiso Malindisa, Martin Bernert, Boitelo T. Letsolo and Stefan F. T. Weiss. (2017). 37 kDa LRP::FLAG enhances telomerase activity and reduces senescent markers in vitro. Oncotarget (In press).
•Naidoo K, Malindisa ST, Otgaar TC, Bernert M, Da Costa Dias B, et al. (2015) Knock-Down of the 37kDa/67kDa Laminin Receptor LRP/LR Impedes Telomerase Activity. PLoS ONE 10(11): e0141618. doi: 10.1371/journal.pone.0141618. Accessed through  http://www.ncbi.nlm.nih.gov/pubmed/26545108
•Jovanovic K, Chetty CJ, Khumalo T, Da Costa Dias B, Ferreira E, Malindisa ST, Caveney R, Letsolo BT, Weiss SF. (2015). Novel patented therapeutic approaches targeting the 37/67 kDa laminin receptor for treatment of cancer and Alzheimer's disease. Expert Opin Ther Pat.;25(5):567-82. Accessed through http://www.ncbi.nlm.nih.gov/pubmed/25747044